| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/31/2001 | EP1071953A1 Detection and diagnosis of conditions associated with lung injury |
| 01/31/2001 | EP1071952A1 I kappa b and enhanced green fluorescent fusion protein |
| 01/31/2001 | EP1071951A1 Modified surface for carrying out or detecting affinity reactions |
| 01/31/2001 | EP1071950A1 Soil test |
| 01/31/2001 | EP1071949A1 Method for determining a gushing factor for a beverage |
| 01/31/2001 | EP1071945A1 Biochemical devices and their methods of manufacture |
| 01/31/2001 | EP1071943A1 Assays for the detection of microtubule depolymerization inhibitors |
| 01/31/2001 | EP1071940A1 Drainage testing of porous asphalt road mixes |
| 01/31/2001 | EP1071939A1 Molecular sensing apparatus and method |
| 01/31/2001 | EP1071845A1 Method and equipment for controlling properties of paper |
| 01/31/2001 | EP1071827A1 Mixed cell diagnostic systems |
| 01/31/2001 | EP1071823A2 Novel mutations in the (freac3 )gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
| 01/31/2001 | EP1071822A2 Fetal testing for prediction of low birth weight |
| 01/31/2001 | EP1071821A1 Methods for reducing non-specific binding to a nucleic acid probe array |
| 01/31/2001 | EP1071819A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine |
| 01/31/2001 | EP1071813A1 Tagged ligand arrays for identifying ligand-target interactions |
| 01/31/2001 | EP1071809A2 Multiparameter facs assays to detect alterations in cellular parameters |
| 01/31/2001 | EP1071787A1 Tao protein kinases and methods of use |
| 01/31/2001 | EP1071783A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 01/31/2001 | EP1071779A1 Vertebrate patched-2 protein |
| 01/31/2001 | EP1071777A2 Human nucleic acid sequences of normal uterus tissue |
| 01/31/2001 | EP1071776A2 Human nucleic acid sequences of normal bladder tissue |
| 01/31/2001 | EP1071774A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 01/31/2001 | EP1071773A1 Sh2 domain-containing peptides |
| 01/31/2001 | EP1071772A2 Fizz proteins |
| 01/31/2001 | EP1071771A2 Gene encoding syntaxin interacting protein |
| 01/31/2001 | EP1071770A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor |
| 01/31/2001 | EP1071761A1 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors |
| 01/31/2001 | EP1071758A1 Porcine adenovirus type 3 genome |
| 01/31/2001 | EP1071752A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 01/31/2001 | EP1071750A1 Pns cell lines and methods of use therefor |
| 01/31/2001 | EP1071749A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 01/31/2001 | EP1071715A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA) |
| 01/31/2001 | EP1071714A1 A novel g-protein coupled receptor |
| 01/31/2001 | EP1071709A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 01/31/2001 | EP1071708A1 Edg family gene, human h218 |
| 01/31/2001 | EP1071706A1 Rapidly degrading gfp-fusion proteins and methods of use |
| 01/31/2001 | EP1071698A1 Nucleic acid sequences and proteins associated with aging |
| 01/31/2001 | EP1071697A1 Regulated target expression for screening |
| 01/31/2001 | EP1071694A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 01/31/2001 | EP1071667A1 Receptor ligands |
| 01/31/2001 | EP1071579A1 Capacitive sensor assembly with soot build-up inhibiting coating |
| 01/31/2001 | EP1071473A1 Acetic acid as a signal enhancing contrast agent in fluorescence spectroscopy |
| 01/31/2001 | EP1071451A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/31/2001 | EP1071444A1 A method of detecting drug-receptor and protein-protein interactions |
| 01/31/2001 | EP1071443A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 01/31/2001 | EP1071436A1 Immune effector cell hybrids |
| 01/31/2001 | EP1071434A1 Cnre binding factors and uses thereof |
| 01/31/2001 | EP1071419A1 Cannabinoids as antioxidants and neuroprotectants |
| 01/31/2001 | EP1071327A1 Autoantigenic fragments, methods and assays |
| 01/31/2001 | EP1034234A4 Stabilized particles and methods of preparation and use thereof |
| 01/31/2001 | EP1011623A4 Wet appliable sunscreen and makeup and method for testing sunscreens for efficacy |
| 01/31/2001 | EP0986435A4 Multiwell plate volume adaptor |
| 01/31/2001 | EP0775310B1 Systems and methods for identifying and controlling interfaces between blood components |
| 01/31/2001 | EP0706569B1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
| 01/31/2001 | EP0610356B1 Treatment of bacterial dysentery |
| 01/31/2001 | CN1282422A Determination of cellular growth abnormality |
| 01/31/2001 | CN1282378A Analyte assay using particulate labels |
| 01/31/2001 | CN1282339A Monoclonal antibody to alpha 2-macroglobulin and its use for detecting glucan |
| 01/31/2001 | CN1282338A A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 01/31/2001 | CN1281985A Hepatitis virus gene detection method |
| 01/31/2001 | CN1281984A Preparation method of antinuclear antibody detection reagent Hep-2 cell antigen fragment and its product |
| 01/31/2001 | CN1281983A Serum tolal bile acid determination reagent |
| 01/31/2001 | CN1281982A Serum high-density LP determination reagent |
| 01/31/2001 | CN1281981A Serum low-density LP determination reagent |
| 01/31/2001 | CN1281980A Serum 1,5-anhydroglucose alcohol determination reagent |
| 01/31/2001 | CN1281979A Multifunctional virus detection safety cover and its preparation method |
| 01/31/2001 | CN1281978A Anti-alpha-fetoprotein antibody labelled by fluorescein and its preparation method |
| 01/31/2001 | CN1281901A Homogeneous pluorescence probe PCR mycobacterium tuberculosis detection method |
| 01/31/2001 | CN1061339C Novel sulfonamide inhibitors of aspartyl protease |
| 01/30/2001 | US6181417 Photometric readhead with light-shaping plate |
| 01/30/2001 | US6181413 Displacing volume in field of view |
| 01/30/2001 | US6180948 Image recording system for evaluating analytical test elements |
| 01/30/2001 | US6180844 A fluorescent dye precursor useful in detecting biological analytes |
| 01/30/2001 | US6180833 Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates |
| 01/30/2001 | US6180776 MTS2 gene |
| 01/30/2001 | US6180773 The cc type chemokines belong to a family of polypeptides which have proven to be mediators of immune reactions, and which have antiviral activity with respect to hiv |
| 01/30/2001 | US6180771 Given nucleotide sequence; useful for pharmaceutical administration or methods of diagnosing sensitivity to house dust mites |
| 01/30/2001 | US6180769 Method for linking negatively charged macrobiomolecules to plastics, resulting linked compositions and microtitre plates incorporating same |
| 01/30/2001 | US6180631 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 01/30/2001 | US6180418 Force discrimination assay |
| 01/30/2001 | US6180417 Immunochromatographic assay |
| 01/30/2001 | US6180415 Interrogating a field having distributed plasmon or resonant entities by illuminating field, detecting spectral emission characteristic of individuals, constructing computer image, discriminating desired entities; sensitive diagnostics |
| 01/30/2001 | US6180414 Breath test for detection of drug metabolism |
| 01/30/2001 | US6180413 Low level TOC measurement method |
| 01/30/2001 | US6180412 Test for chlorine in water |
| 01/30/2001 | US6180411 Chromophore incorporating a photolabile group capable of undergoing an irreversible and detectable intramolecular transformation; chromophore is linked to binding site for analyte; for intracelluar analysis |
| 01/30/2001 | US6180409 For inspecting reagent strip having many pads after strip has been contacted with fluid sample; includes conveyor system, readheads to optically inspect the pads, and automatic positioning system; diagnosis |
| 01/30/2001 | US6180408 Detecting target site on template nucleic acid by chain extension and termination using fluorescently labeled dideoxynucleotide, then detecting polarization of fluorophore; sensitive, automatic diagnosis and genotyping |
| 01/30/2001 | US6180395 Reagent chamber for test apparatus and test apparatus |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180384 Compounds |
| 01/30/2001 | US6180380 Cloning of a new member of the serine threonine kinase family |
| 01/30/2001 | US6180377 Humanized antibodies |
| 01/30/2001 | US6180369 Varicella-zoster virus antigen |
| 01/30/2001 | US6180368 Ryegrass pollen allergen |
| 01/30/2001 | US6180358 Detecting modulators of kinase activity; incubate modulator with cells expressing kinase polypeptide, detect modulation of kinase activity |
| 01/30/2001 | US6180357 Preparation of preferential anticarcinogenic immunoglobulins; isolating tumor tissue, generating immunoglobulins, test immunoglobulins for preferential toxicity to tumor |
| 01/30/2001 | US6180356 Membrane pore inhibiting agents for treating infection |
| 01/30/2001 | US6180355 Method for diagnosing and treating chronic pelvic pain syndrome |